EA improved PCOS-IR by down-regulating hypothalamic NFκB protein expression and significantly reduced abdominal circumference, body weight, serum fasting glucose, fasting insulin, and IR in rats [83]. This evidence concerns the gene INS and polycystic ovary syndrome.